Billing frequency is stated, not implied
Four plan lengths are priced for each drug, and each one carries its billing cadence in words directly under the rate. That turns a column of per-month figures into four different products rather than four discounts on one, which is what they actually are.
It matters because a per-month figure derived from an annual prepayment behaves nothing like a monthly charge. Leaving early forfeits months already paid for; a bad reaction in week three is a year already spent. The site does not hide any of that, and a reader who takes the cheapest number without reading the line beneath it has been told.
The headline is the annual plan
The advertised entry rate for both molecules is the twelve-month one. It is a real price and it is a substantial saving against the month-to-month rate, but it is not a monthly rate and this page does not present it as one.
The month-to-month figures are recorded here as the monthly rates, and the annual ones are recorded without a per-month suffix. That is not a judgement about which is better value. It is the difference between a number you can leave behind next month and one you have already spent.
The price holds through titration
Within a chosen plan the rate does not change with dose. That protects a patient through the part of treatment where dose-tiered pricing hurts most, which is the point at which the medication starts working and the bill would otherwise climb with it.
Both brand equivalents are named for each compound, so a reader can see which approved product the compounded version corresponds to. That is a small courtesy and a surprisingly uncommon one.
What the plans page does not say
Nothing states whether a membership or platform fee applies. A plan-length table is the wrong instrument for that question and this one does not attempt it, so the position is recorded here as not published rather than as an absence of fees.
The compounding pharmacy is described as a 503A licensed facility and never named. No state list appears; the site says nationwide, which is a claim about ambition rather than a licensure footprint. No individual prescribing clinician or medical director is named.
Voxy Health's published pricing
| Medication | Price | Verified |
|---|---|---|
| Semaglutide (compounded) | $179/moper month on the one-month plan, which the page states is billed monthly | September 2026source |
| Semaglutide (compounded) | $129the per-month figure the page advertises for its twelve-month plan, which the same page states is billed annually — nothing is charged monthly at this rate | September 2026source |
| Tirzepatide (compounded) | $299/moper month on the one-month plan, which the page states is billed monthly | September 2026source |
| Tirzepatide (compounded) | $199the per-month figure the page advertises for its twelve-month plan, which the same page states is billed annually — nothing is charged monthly at this rate | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 283 providers reviewed here are paid partners today; the other 279 are not. See how this works.
See Voxy Health's current price →Good fit if
- Readers who want to know exactly when they will be charged, not just how the rate reads per month.
- Patients confident enough of a full course to prepay a year and take the largest discount on the table.
- Anyone titrating up who wants the figure to stay where it started.
- Readers who want the brand equivalent named beside each compounded molecule.
Look elsewhere if
- Anyone comparing headline numbers across sellers, because this one is an annual prepayment and most competitors quote a monthly charge.
- Patients who want the membership position stated rather than left unaddressed.
- Readers who need to confirm their state is served before starting.
- Anyone who requires the compounding pharmacy to be named.
How this review was verified
- Read the GLP-1 plans page at its source URL and logged all four plan rates for each molecule with the date they were read.
- Recorded the billing cadence the page states beside each rate, and used it to decide which figures are monthly and which are not.
- Recorded the annual-plan figures without a per-month suffix, because the page states they are billed annually.
- Recorded the membership position as not published rather than as an absence, since the plans page addresses the question nowhere.
- Pulled all 3,677 rows of the FDA warning-letter table and filtered them locally with a known-positive and a nonsense-string control in the same run; no letter found.